Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: International metabolic prognostic index

According to recent research, a prognostic model combining baseline metabolic tumor volume, age, and disease stage is a better predictor of progression-free and overall survival among patients with newly diagnosed DLBCL, compared with the International Prognostic Index.